Stock OMND OPTIMIND PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Optimind Pharma Corp.

Equities

OMND

CA68405U1012

Biotechnology & Medical Research

Delayed Canadian Securities Exchange
Other stock markets
 20:09:39 03/06/2024 BST 		5-day change 1st Jan Change
0.005 CAD -50.00% Intraday chart for Optimind Pharma Corp. 0.00% 0.00%
01-26 Optimind Pharma Reaches Agreement On Debenture Conversion MT
01-10 Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 CI

Valuation

Fiscal Period: February 2023
Capitalization 1 3.914
Enterprise Value (EV) 1 3.975
P/E ratio -1.07 x
Yield -
Capitalization / Revenue 23 x
EV / Revenue 23.4 x
EV / EBITDA -4.45 x
EV / FCF -5,537,853 x
FCF Yield -0%
Price to Book 6.12 x
Nbr of stocks (in thousands) 97,852
Reference price 2 0.0400
Announcement Date 28/06/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2022 2023
Net sales 1 0.0997 0.1701
EBITDA 1 -0.3949 -0.8936
EBIT 1 -0.4041 -0.9074
Operating Margin -405.39% -533.41%
Earnings before Tax (EBT) 1 -0.4212 -3.087
Net income 1 -0.2777 -3.078
Net margin -278.57% -1,809.57%
EPS 2 -0.006370 -0.0375
Free Cash Flow - -0.7178
FCF margin - -421.98%
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 28/06/23 28/06/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: February 2022 2023
Net Debt 1 - 0.06
Net Cash position 1 1.22 -
Leverage (Debt/EBITDA) - -0.0685 x
Free Cash Flow - -0.72
ROE (net income / shareholders' equity) - -167%
ROA (Net income/ Total Assets) - -21.9%
Assets 1 - 14.03
Book Value Per Share 2 0.0700 0.0100
Cash Flow per Share 2 0.0300 0.0100
Capex - -
Capex / Sales - -
Announcement Date 28/06/23 28/06/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
OPTIMIND PHARMA CORP. Stock Optimind Pharma Corp.
0.00% 358K
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+18.45% 123B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+14.73% 107B
BIONTECH SE Stock BioNTech SE
-4.47% 24.01B
ARGENX SE Stock argenx SE
+2.18% 22.59B
GENMAB A/S Stock Genmab A/S
-10.09% 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.04% 16.84B
BEIGENE, LTD. Stock BeiGene, Ltd.
-12.34% 16.23B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.38% 13.43B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+24.39% 11.32B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. OMND Stock
  4. Financials Optimind Pharma Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW